Self-Advocacy | Why In-Depth Cancer Testing Is Essential
https://vimeo.com/1143931847 Dr. Heidi Gray explains why speaking up and asking about in-depth cancer testing can make a real difference in understanding your cancer care. With today’s rapidly evolving testing options…
Molecular Testing and Hereditary Testing: What’s the Difference?
https://vimeo.com/1143931665 What is the difference between hereditary (genetic) testing and molecular testing in cancer care? Dr. Heidi Gray defines the tests in simple terms and shares how test results can…
When Should Someone With Cancer Undergo Molecular Testing?
https://vimeo.com/1133948722 Cancer researcher Dr. Paul Oberstein explains when patients should undergo molecular testing and why early testing can be crucial. Dr. Oberstein also discusses new methods like blood-based assays that…
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
https://vimeo.com/1133948743 Dr. Paul Oberstein explains how molecular testing has revolutionized cancer care, providing doctors with an essential tool to personalize treatment and, in many cases, improve outcomes for people with…
INSIST! AML Resource Guide | Testing
Download Guide Download Guide See More from INSIST! AML
Advances in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (AML)
https://vimeo.com/841012721 AML expert Dr. Omer Jamy discusses his approach when considering treatment for patients with relapsed or refractory AML, including transplant eligibility, molecular markers, and whether clinical trials may be…
What Is the AGILE Study? Research for AML Patients With the IDH1 Mutation
https://vimeo.com/841012970 AML expert Dr. Omer Jamy reviews the results of the AGILE study, a clinical trial evaluating the efficacy and safety of ivosidenib + azacitidine vs placebo + azacitidine in…
Expert Advice | Shining a Light on Equitable AML Care
https://vimeo.com/825226188 While treatment options are improving, there are still many factors impacting equitable care for AML patients. Dr. Ann-Kathrin Eisfeld shares advice for improving research and clinical trials for underserved…
Emerging AML Treatment Classes Showing Promise
https://vimeo.com/825225712 What therapies are in development for acute myeloid leukemia (AML)? Dr. Ann-Kathrin Eisfeld discusses the latest research for AML treatment, including menin inhibitors and CAR T-cell therapy. Dr. Ann-Kathrin…
AML Treatment Approaches | Factors That Impact Options
https://vimeo.com/825224825 What factors are considered when choosing an AML treatment approach? Dr. Ann-Kathrin Eisfeld explains how shared decision-making comes into play when deciding on a therapy and reviews the options…
How Have Advances in Testing Impacted AML Care?
https://vimeo.com/825225812 Recent testing advances have dramatically improved care for AML patients. Dr. Ann-Kathrin Eisfeld discusses these improvements and why every AML patient should undergo in-depth molecular testing before making a…
Low-Risk Versus High-Risk AML
https://vimeo.com/825225958 How is AML risk determined, and how does it affect treatment options? Dr. Ann-Kathrin Eisfeld defines low-risk and high-risk AML and explains how this classification may predict disease response…